SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies, Inc. (NYSE: A) today announced that it has entered into a definitive agreement to acquire privately-held Genohm, a developer of highly ...
ST. LOUIS--(BUSINESS WIRE)--Partek ® Incorporated announced today they have entered into an agreement with Agilent to integrate Partek ® Flow ® bioinformatics software with the Agilent Alissa Clinical ...
Join us for the VIP Laboratory Informatics Executive Leadership Roundtable. This is an invitation only event. This is an interactive forum among VIP Laboratory Informatics executives and Agilent ...
GeneGo, Inc. has announced the ability to integrate GeneGo's MetaCore and Agilent Technologies Inc.'s GeneSpring software applications. Users of both will enjoy the interoperability between the two ...
Genohm’s main laboratory software automation product, called SLIMS, is a digital platform that provides users with a laboratory information management system (LIMS) and electronic lab notebook (ELN) ...
Accelrys Inc. and Agilent Technologies Inc. announced they have entered into a comprehensive resale agreement to enable the licensing and integration of their informatics products. The partnership ...
Release > Arizona State University spotlights the work of one of its Ph.D. candidate's work on using algorithms and data design for cancer research. Item > Franklin, TN-based MedQuist Holdings, a ...
Bioinformatics Market By Type (Bioinformatics Products, Bioinformatics Services), By Bioinformatics Products (Knowledge Management Tools, Bioinformatics Platforms), By Application (Genomics, ...
The scientific instrument maker Agilent Technologies has purchased an artificial intelligence business from the software developer Virtual Control. Agilent will use the AI along with its MassHunter ...
Good day, ladies and gentlemen, and welcome to the Q3 2018, Agilent Technologies Inc Earnings Conference Call. At this time, all participants are in a listen-only mode. Following management's prepared ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results